Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia
Sponsor: Arrowhead Regional Medical Center
Summary
This study aims to assess whether administering intravenous iron early in pregnancy, compared to standard oral iron treatment, can enhance hemoglobin levels before delivery and reduce the need for blood transfusions in patients with iron deficiency anemia. Patients diagnosed with iron deficiency anemia were randomly assigned to receive either oral or intravenous iron. Before treatment initiation, patients completed a symptom questionnaire baseline hemoglobin, and ferritin levels were measured. Follow-up visits occurred four weeks later and at 24 to 28 weeks gestation, involving reassessment of symptoms, laboratory testing, and monitoring of treatment adherence. Final hemoglobin levels were determined before delivery, and data on the need for blood transfusion at delivery were recorded.
Official title: Randomized Control Trial: Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia in Pregnancy
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
900
Start Date
2023-11-21
Completion Date
2025-12-30
Last Updated
2024-04-16
Healthy Volunteers
Yes
Conditions
Interventions
Venofer 200 MG Per 10 ML Injection
200 mg IV every 2 days until the targeted dose
Ferrous sulfate
Take 1 tablet every other day with lemon/orange juice
Locations (1)
Arrowhead Regional Medical Center
Colton, California, United States